Document ID: chunk:federal_register_of_legislation:F2023L01747:schedule:1:p10
Version: federal_register_of_legislation:F2023L01747
Segment Type: schedule
Provision Reference: sch 1 (pt 10/31)
Character Range: 31597–34937

NP  C8774 C8775 C8776 C8780 C8827         P8776 P8780 P8827  30  5  30

         (b)           insert in the columns in the order indicated, and in alphabetical order for the column headed "Brand":
            Esomeprazole Viatris  MQ  MP  C8774 C8775 C8776 C8780 C8827 C11310  P8776 P8780 P8827  30  5  30
                                      NP  C8774 C8775 C8776 C8780 C8827         P8776 P8780 P8827  30  5  30

     [41]               Schedule 1, Part 1, entry for Esomeprazole in the form Tablet (enteric coated) 20 mg (as magnesium trihydrate) [Maximum Quantity: 60; Number of Repeats: 5]
         (a)           omit:
            Esomeprazole Apotex  TX  MP  C8774 C8775 C8776 C8780 C8827 C11310  P11310  60  5  30

         (b)           insert in the columns in the order indicated, and in alphabetical order for the column headed "Brand":
            Esomeprazole Viatris  MQ  MP  C8774 C8775 C8776 C8780 C8827 C11310  P11310  60  5  30

     [42]               Schedule 1, Part 1, entry for Esomeprazole in the form Tablet (enteric coated) 40 mg (as magnesium trihydrate) [Maximum Quantity: 30; Number of Repeats: 1]
         (a)           omit:
            Esomeprazole Apotex  TX  MP  C8777 C8778 C8902 C11370  P8902  30  1  30
                                     NP  C8777 C8778 C8902         P8902  30  1  30

         (b)           insert in the columns in the order indicated, and in alphabetical order for the column headed "Brand":
            Esomeprazole Viatris  MQ  MP  C8777 C8778 C8902 C11370  P8902  30  1  30
                                      NP  C8777 C8778 C8902         P8902  30  1  30

     [43]               Schedule 1, Part 1, entry for Esomeprazole in the form Tablet (enteric coated) 40 mg (as magnesium trihydrate) [Maximum Quantity: 30; Number of Repeats: 5]
         (a)           omit:
            Esomeprazole Apotex  TX  MP  C8777 C8778 C8902 C11370  P8777 P8778  30  5  30
                                     NP  C8777 C8778 C8902         P8777 P8778  30  5  30

         (b)           insert in the columns in the order indicated, and in alphabetical order for the column headed "Brand":
            Esomeprazole Viatris  MQ  MP  C8777 C8778 C8902 C11370  P8777 P8778  30  5  30
                                      NP  C8777 C8778 C8902         P8777 P8778  30  5  30

     [44]               Schedule 1, Part 1, entry for Esomeprazole in the form Tablet (enteric coated) 40 mg (as magnesium trihydrate) [Maximum Quantity: 60; Number of Repeats: 5]
         (a)           omit:
            Esomeprazole Apotex  TX  MP  C8777 C8778 C8902 C11370  P11370  60  5  30

         (b)           insert in the columns in the order indicated, and in alphabetical order for the column headed "Brand":
            Esomeprazole Viatris  MQ  MP  C8777 C8778 C8902 C11370  P11370  60  5  30

     [45]               Schedule 1, Part 1, entry for Ferric derisomaltose in each of the forms: Injection 500 mg (iron) in 5 mL; and Injection 1000 mg (iron) in 10 mL
     omit from the column headed "Responsible Person": PF substitute: FK

     [46]               Schedule 1, Part 1, entry for Flucloxacillin in the form Capsule 250 mg (as sodium monohydrate)
     omit:
         a  APO-Flucloxacillin  TX  MP NP MW  C5414     24  0  24
                                    PDP       C5298     24  0  24